Evidence map›Paper›PMID 41838520›Full record

ArticleVirulence2026

Antibacterial efficacy and mechanism of the novel antimicrobial peptide lachnospirin-1 against

Pengfei She, Mengna Li, Yiqing Liu, Guanqing Huang, Shaowei Guo, Dan Xiao, Yelan Hong, Lihua Lu, Yong Wu

Abstract read
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pengfei SheDepartment of Laboratory Medicine, The Third Xiangya Hosipital, Central South University, Changsha, China.ORCID 0000-0002-4246-1361
Mengna LiDepartment of Laboratory Medicine, Xiangya Hosipital, Central South University, Changsha, China.
Yiqing LiuDepartment of Laboratory Medicine, Xiangya Hosipital, Central South University, Changsha, China.
Guanqing HuangDepartment of Laboratory Medicine, Xiangya Hosipital, Central South University, Changsha, China.
Shaowei GuoDepartment of Laboratory Medicine, Changsha First Hospital (Affiliated Changsha Hospital of Xiangya School of Medicine Central South University ), Changsha, China.
Dan XiaoDepartment of Laboratory Medicine, Changsha First Hospital (Affiliated Changsha Hospital of Xiangya School of Medicine Central South University ), Changsha, China.
Yelan HongDepartment of Laboratory Medicine, Changsha First Hospital (Affiliated Changsha Hospital of Xiangya School of Medicine Central South University ), Changsha, China.
Lihua LuDepartment of Laboratory Medicine, Changsha First Hospital (Affiliated Changsha Hospital of Xiangya School of Medicine Central South University ), Changsha, China.
Yong WuDepartment of Laboratory Medicine, Xiangya Hosipital, Central South University, Changsha, China.ORCID 0000-0002-3667-8716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of carbapenem-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAcinetobacter InfectionsAnimalsBiofilmsCell MembraneMiceMicrobial Sensitivity TestsOxidative StressAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial Peptidesacinetobacter baumanniiAntimicrobial peptidecarbapenem-resistancecell membranelipopolysaccharideoxidative stress

Identifiers

PMID41838520
PMCPMC13007424

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.